City of Hope is a clinical research site located in Irvine, California, United States 92618.
Crixeo Clinical Trials Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
City of Hope has participated in 8 clinical trials with 6 currently active.
Therapeutic areas: Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation.
Sponsors: Pierre Fabre Medicament, ORIC Pharmaceuticals, Bolt Biotherapeutics, Inc..
Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
City of Hope has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
City of Hope has 8 clinical trials on record, with 6 currently active. Their work covers Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation.
City of Hope has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.